Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Frailty × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 21 Genitourinary 8 Other hematologic neoplasm 6 Gynecologic 5 Breast 4 Thoracic 2 Plasma cell 2 Lymphoid 2 Head & Neck 2 NET 1 Myeloid 1 Endocrine 1

Conditions

Neuroendocrine Tumors 345 Multiple Endocrine Neoplasia Type 1 141 Pituitary Neoplasms 140 Thyroid Cancer, Papillary 106 Pheochromocytoma 93 Carcinoma, Neuroendocrine 86 Thyroid Neoplasms 66 Carcinoid Tumor 58 Paraganglioma 56 Neoplasms 52 Adrenal Gland Neoplasms 43 Thyroid Carcinoma, Anaplastic 42 Adrenocortical Carcinoma 42 Insulinoma 36 Pancreatic Neoplasms 33 Gastro-enteropancreatic neuroendocrine tumor 33 Adenoma, Islet Cell 33 Neoplasm Metastasis 32 Carcinoma, Medullary 26 Neuroblastoma 25 Prostatic Neoplasms 24 Hyperaldosteronism 23 Adenocarcinoma, Follicular 23 Obesity 22 Lung Neoplasms 21 Pituitary Diseases 20 Brain Neoplasms 20 Sarcoma 18 Meningioma 18 Gastrointestinal Neoplasms 18

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05554003 2024-11-18

MeTe

European Institute of Oncology

Phase 2 Recruiting

Frailty, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡